Tandem Diabetes Care (TNDM) Non-Current Debt (2013 - 2018)
Tandem Diabetes Care's (TNDM) quarterly Non-Current Debt came in at $77.1 million in Q2 2018, up 3.24% YoY from $74.7 million in Q2 2017, and up 0.91% on a QoQ basis from $76.4 million in Q1 2018.
Tandem Diabetes Care (TNDM) Non-Current Debt (2013 - 2018) Analysis & Trends
Tandem Diabetes Care (TNDM) has 6 years of Non-Current Debt data on file, last reported at $77.1 million in Q2 2018.
- Quarterly Non-Current Debt rose 3.24% year-over-year to $77.1 million in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $77.1 million (up 3.24% YoY) and the FY2017 annual result came in at $76.5 million, down 3.06% from the prior year.
- Non-Current Debt grew to $77.1 million in Q2 2018, from $76.4 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $79.0 million in Q4 2016 to a low of $29.3 million in Q4 2015.
- A 5-year average of $50.1 million and a median of $44.3 million in 2016 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2016 — Non-Current Debt surged 169.72% — and 2017, when it decreased 3.06%.
- Tracing TNDM's Non-Current Debt over 5 years: stood at $29.4 million in 2014, then decreased by 0.56% to $29.3 million in 2015, then surged by 169.72% to $79.0 million in 2016, then retreated by 3.06% to $76.5 million in 2017, then climbed by 0.73% to $77.1 million in 2018.
- The last three Non-Current Debt figures came in at $77.1 million (Q2 2018), $76.4 million (Q1 2018), and $76.5 million (Q4 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Tandem Diabetes Care | 1.57 Bn | 1.11 Bn | 144.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 77.10 Mn |
| Mar 31, 2018 | 76.41 Mn |
| Dec 31, 2017 | 76.54 Mn |
| Sep 30, 2017 | 75.60 Mn |
| Jun 30, 2017 | 74.68 Mn |
| Mar 31, 2017 | 73.76 Mn |
| Dec 31, 2016 | 78.96 Mn |
| Sep 30, 2016 | 44.68 Mn |
| Jun 30, 2016 | 44.40 Mn |
| Mar 31, 2016 | 44.11 Mn |
| Dec 31, 2015 | 29.28 Mn |
| Sep 30, 2015 | 29.50 Mn |
| Jun 30, 2015 | 29.48 Mn |
| Mar 31, 2015 | 29.46 Mn |
| Dec 31, 2014 | 29.44 Mn |
| Sep 30, 2014 | 29.42 Mn |
| Jun 30, 2014 | 29.39 Mn |
| Mar 31, 2014 | 29.44 Mn |
| Dec 31, 2013 | 29.40 Mn |